Prognostic Value of Coronary and Microvascular Flow Reserve in Patients with Nonischemic Dilated Cardiomyopathy

Carregando...
Imagem de Miniatura
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
MOSBY-ELSEVIER
Citação
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, v.26, n.3, p.278-287, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Coronary and microvascular blood flow reserve have been established as important predictors of prognosis in patients with cardiovascular disease. The aim of this study was to assess the value of coronary flow velocity reserve (CFVR) and real-time myocardial perfusion echocardiography (RTMPE) for predicting events in patients with nonischemic dilated cardiomyopathy. Methods: One hundred ninety-five patients (mean age 54 +/- 12 years; 66% men) with dilated cardiomyopathy (left ventricular ejection fraction < 35% and no obstructive coronary disease on invasive angiography or multi-detector computed tomography) who underwent dipyridamole stress (0.84 mg/kg over 10 min) RTMPE were prospectively studied. CFVR was calculated as the ratio of hyperemic to baseline peak diastolic velocities in the distal left anterior coronary artery. The replenishment velocity (beta), plateau of acoustic intensity (A(N)), and myocardial blood flow reserve were obtained from RTMPE. Results: Mean CFVR was 2.07 +/- 0.52, mean A(N) reserve was 1.05 +/- 0.09, mean beta reserve was 2.05 +/- 0.39, and mean myocardial blood flow reserve (A(N) x beta) was 2.15 +/- 0.48. During a median follow-up period of 29 months, 45 patients had events (43 deaths and two urgent transplantations). Independent predictors of events were left atrial diameter (relative risk, 1.16; 95% confidence interval, 1.08-1.26; P < .001) and beta reserve <= 2.0 (relative risk, 3.22; 95% confidence interval, 1.18-8.79; P < .001). After adjustment for beta reserve, CFVR and myocardial blood flow reserve no longer had predictive value. Left atrial diameter added prognostic value over clinical factors and left ventricular ejection fraction (chi(2) = 36.8-58.5, P < .001). Beta reserve added additional power to the model (chi(2) = 70.2, P < .001). Conclusions: Increased left atrial diameter and depressed beta reserve were independent predictors of cardiac death and transplantation in patients with nonischemic dilated cardiomyopathy. Beta reserve by RTMPE provided incremental predictive value beyond that provided by current known prognostic clinical and echocardiographic factors. (J Am Soc Echocardiogr 2013;26:278-87.)
Palavras-chave
Dilated cardiomyopathy, Contrast echocardiography, Myocardial perfusion, Prognostic value, Myocardial blood flow reserve
Referências
  1. Aaronson KD, 1997, CIRCULATION, V95, P2660
  2. Abdelmoneim SS, 2009, EUR J ECHOCARDIOGR, V10, P813, DOI 10.1093/ejechocard/jep084
  3. Anantharam B, 2011, EUR J ECHOCARDIOGR, V12, P69, DOI 10.1093/ejechocard/jeq109
  4. Butler J, 2004, J AM COLL CARDIOL, V43, P787, DOI 10.1016/j.jacc.2003.08.058
  5. Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975
  6. Chen JW, 1999, INT J CARDIOL, V69, P251, DOI 10.1016/S0167-5273(99)00042-X
  7. Drozdz J, 2002, CHEST, V121, P1216, DOI 10.1378/chest.121.4.1216
  8. Erdogan D, 2012, PLATELETS, V23, P177, DOI 10.3109/09537104.2011.611273
  9. Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064
  10. Kizer JR, 2006, AM HEART J, V151, P412, DOI 10.1016/j.ahj.2005.04.031
  11. Kowatsch I, 2007, J AM SOC ECHOCARDIOG, V20, P1109, DOI 10.1016/j.echo.2007.02.008
  12. Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
  13. Mulvagh SL, 2008, J AM SOC ECHOCARDIOG, V21, P1179, DOI 10.1016/j.echo.2008.09.009
  14. Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023
  15. NEGLIA D, 1995, CIRCULATION, V92, P796
  16. Neglia D, 2002, CIRCULATION, V105, P186, DOI 10.1161/hc0202.102119
  17. Osorio AF, 2007, J AM SOC ECHOCARDIOG, V20, P709, DOI 10.1016/j.echo.2006.11.016
  18. Peltier M, 2004, J AM COLL CARDIOL, V43, P257, DOI 10.1016/j.jacc.2003.07.040
  19. PORTER TR, 1995, CIRCULATION, V92, P2391
  20. Pratali L, 2001, AM J CARDIOL, V88, P1374, DOI 10.1016/S0002-9149(01)02116-6
  21. Quinones MA, 2000, J AM COLL CARDIOL, V35, P1237, DOI 10.1016/S0735-1097(00)00511-8
  22. Rainbird AJ, 2001, J AM SOC ECHOCARDIOG, V14, P378, DOI 10.1067/mje.2001.111264
  23. REED D, 1991, CIRCULATION, V84, P23
  24. Rigo F, 2007, AM J CARDIOL, V99, P1154, DOI 10.1016/j.amjcard.2006.11.049
  25. Rigo F, 2006, EUR HEART J, V27, P1319, DOI 10.1093/eurheartj/ehi795
  26. Santos JMT, 2010, AM J CARDIOL, V105, P243, DOI 10.1016/j.amjcard.2009.09.009
  27. Takemoto Y, 2005, AM J CARDIOL, V96, P832, DOI 10.1016/j.amjcard.2005.05.031
  28. Tsagalou EP, 2008, J AM COLL CARDIOL, V52, P1391, DOI 10.1016/j.jacc.2008.05.064
  29. Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3
  30. Tsutsui JM, 2008, AM HEART J, V156, P1110, DOI 10.1016/j.ahj.2008.07.015
  31. Tsutsui JM, 2005, CIRCULATION, V112, P1444, DOI 10.1161/CIRCULATIONHA.105.537134
  32. Vogel R, 2005, J AM COLL CARDIOL, V45, P754, DOI 10.1016/j.jacc.2004.11.044
  33. Wei K, 1998, CIRCULATION, V97, P473
  34. Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3